| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Metagenomi, Inc. | Chief Executive Officer, Director | Common Stock | 564K | $999K | $1.77 | Dec 5, 2025 | Direct |
| Metagenomi, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 225K | Dec 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MGX | Metagenomi, Inc. | Dec 5, 2025 | 1 | -$2.84K | 4 | Dec 8, 2025 | Chief Executive Officer, Director |
| MGX | Metagenomi, Inc. | Sep 5, 2025 | 4 | $395K | 4 | Dec 1, 2025 | Chief Executive Officer, Director |
| MGX | Metagenomi, Inc. | Jun 6, 2025 | 1 | -$11.2K | 4 | Jun 9, 2025 | Title: President and Chief Operating Officer, Director |
| MGX | Metagenomi, Inc. | Apr 1, 2025 | 2 | $0 | 4 | Apr 3, 2025 | Title: President and Chief Operating Officer, Director |
| MGX | Metagenomi, Inc. | Apr 1, 2024 | 2 | $0 | 4 | Apr 3, 2024 | Title: President and Chief Operating Officer, Director |
| MGX | Metagenomi Technologies, LLC | Feb 8, 2024 | 0 | $0 | 3 | Feb 8, 2024 | Title: President and Chief Operating Officer; Exhibit 24 - Power of Attorney, Director |